This blog is part of our People Behind Purpose at Cisco series that focuses on employees driving Cisco’s purpose to Power an Inclusive Future for All. Each blog highlights a different Cisco employee whose work positively impacts people, communities, or the planet. The series was formerly known as people behind Corporate Social Responsibility (CSR) at Cisco.

Where the materials in a company’s supply chain come from matters; to customers, to global communities, and to us at Cisco. Cisco´s purpose is to Power an Inclusive Future for All. We have a long-standing commitment to uphold and respect the human rights of all people, wherever we operate, including those who work in our supply chain. Our dedication to human rights is embedded in our due diligence system, which is consistent with our Global Human Rights Policy, the United Nations Guiding Principles on Business and Human Rights (UNGPs), and the Organisation for Economic Co-operation and Development (OECD) Due Diligence Guidelines for Responsible Business Conduct.

That’s why Cisco employee Chrysantha Davis, project specialist for responsible sourcing on Cisco’s Supply Chain Sustainability team, dedicates herself to supporting our suppliers’ consistency across our supply chain in regard to our policies and standards for ethical and responsible sourcing of minerals.

Here’s what you should know about Chrysantha and the critical work she does at Cisco.

Q: How did an internship at Cisco lead to your current position?

Chrysantha: In college, I studied a curriculum with a lot of touchpoints on sustainability. After graduating, I accepted an internship on Cisco’s Global Manufacturing Operations team at a time when internship opportunities in the sustainability field were still limited but growing. During that time, I entered a Cisco Supply Chain case study competition with a project on recycled tin, having no idea that one day I would segue into the minerals space. I have always had an interest in sustainability, and through working on my project, I gained a lot of exposure to sustainability at Cisco, and specifically to the work the Supply Chain Sustainability team does.

Later on, I applied for a position as Project Specialist on the team, which I’ve been in for a little over two and a half years. In my current role, I manage the due diligence of our Responsible Minerals program, specifically for sourcing “3TG” — tantalum, tin, tungsten, and gold — found in Cisco’s hardware products. I engage with our suppliers across the supply chain and work with them to source minerals in a manner consistent with our values around human rights, business ethics, labor, health and safety practices, and environmental responsibility.

Q: When suppliers do not meet Cisco’s expectations, why does Cisco prefer to work with them to improve performance, rather than seek out other suppliers?

Chrysantha: Minerals are essential to manufacturing our products, and so is upholding our Responsible Minerals Policy, which requires our suppliers to source 3TG and cobalt from smelters and refiners that conform to an audit assurance process. We want them to understand the importance of practicing responsible sourcing, as well as the benefits to them. If we immediately switched suppliers instead of working with them, they might not improve their performance.

Having good relationships with suppliers matters, and since I’ve been on board, we’ve been able to work with them successfully to switch to alternative sourcing as necessary.

Q: How does Cisco leverage industry and other stakeholder groups?

Chrysantha: In addition to exercising leverage directly with our suppliers, we also collaborate with industry peers. Cisco has been a member of the Responsible Business Alliance (RBA) since April 2008, and is a participant in RBA’s Responsible Materials Initiative (RMI). The RMI is a collaborative forum and provides tools and resources to Cisco and peer companies to move forward as an industry vis-à-vis responsible sourcing in the minerals space.

The Cisco Supply Chain Sustainability team utilizes the Conflict Minerals Reporting template (CMRT), a standardized survey template RMI provides without charge. We use this survey when onboarding a new supplier to help determine whether smelters or refiners in their supply chain can pose risk. We also require hardware suppliers across our supply chain to complete an updated CMRT annually. If a supplier reports smelters that are not conformant to a third-party audit scheme, we work directly with them to help switch to alternative sourcing.

Other organizations we work closely with include the European Partnership for Responsible Minerals, whose Scalable Trade in Artisanal Gold project focuses on establishing a commercially viable pathway to selling responsibly sourced artisanal gold. And as mentioned previously, there’s also the OECD, an intergovernmental agency, some of whose guiding principles on human rights and environmental sustainability are incorporated into Cisco’s Responsible Minerals Policy.

Q: What are some of the challenges you face in your day-to-day work?

Chrysantha: Reviewing and interpreting new regulations and requirements from a range of stakeholders (e.g. customers, partners, investors, governments) before they take effect.

We make sure our suppliers provide us with their most current information, such as changes to a smelter’s status, which may impact dozens of our suppliers. We must also stay in close communication with the RMI, which has monthly sessions to announce upcoming changes to conformance listings.

Q: What can you share about working collaboratively with other Cisco internal organizations to integrate risk mitigation into operations?

Chrysantha: The Cisco Global Supplier Management team owns the relationship with our suppliers, so we work very closely with them to help keep them informed on current compliance guidelines and issues, which in turn they can communicate to suppliers.

We also work closely with the Cisco Business and Human Rights and Government Affairs teams regarding new guidelines and regulations that can impact our supply chain operations.

Q: Where do you find your purpose in doing your day-to-day work?

Chrysantha: I find purpose in knowing that my team is doing what we can to positively impact the lives of the people and communities in our supply chain. Also, being surrounded by thoughtful and passionate people helps me stay motivated and is a great reminder we are all trying to accomplish the same goal.

Q: Do you have any specific advice for anyone interested in a career in responsible sourcing for a supply chain?

Chrysantha: There may be a perception that the sustainability field is a challenging career choice, and I think in some ways it can be. But, as I mentioned earlier, this is my first job out of college, and I’ve been able to learn a lot from my team by just performing my job. Opportunities in sustainability are growing tremendously right now. It doesn’t matter at what point in your career you get into this field; sustainability is a space that can be accessible to everyone.

For those still in college, internships are a great way to dip your toes into this field. As an intern, I had the opportunity to grow my network within my team and learn more about what Cisco is doing in sustainability. If you’re already at a company with a sustainability program and want to get involved doing that work, consider taking on a sustainability stretch assignment, a project that challenges you to go beyond what you already know or your skill level.

Cisco is actively recruiting for its Supply Chain group. For more information, visit Cisco Careers.

Learn more about Cisco’s long-standing commitment to human rights in the supply chain at Cisco´s environmental, social, and governance (ESG) Reporting Hub and by reading our calendar year 2021 Cisco conflict minerals report.

You can find People Behind Purpose and other Cisco Corporate Social Responsibility blogs at https://blogs.cisco.com/csr.

View original content here

– Successfully Met Goals Outlined in MassBio’s Diversity, Equity, and Inclusion (DE&I) Industry Pledge –  

– New Disclosures of Company’s Impact on Planet—Including Multiyear Data on Scope 1, Scope 2, and Select Scope 3 Greenhouse Gas (GHG) Emissions –

CAMBRIDGE, Mass., May 3, 2023 /3BL Media/ – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today published its 2022 Corporate Responsibility Report. This year’s edition reasserts our commitment to advancing pioneering RNAi science and supporting health equity. The company continues to take meaningful steps across each of our six corporate responsibility pillars to ensure everyone has access to essential health services and medicines. As the company further these efforts, it will regularly communicate its progress.

“Our dedication to ethical and responsible business practices is a key enabler for our long-term success.” said Yvonne Greenstreet, MBChB, MBA, Chief Executive Officer of Alnylam. “We see ourselves as industry leaders with a responsibility to achieve ambitious business goals – goals that must also tackle the barriers in place for millions around the world with limited access to quality healthcare and medicines.” 

Key highlights from the 2022 report include:

Met all Diversity, Equity, and Inclusion (DE&I) goals in MassBio’s Industry pledge. Launched formal U.S. supplier diversity program delivering on 2020 pledge to address inequity through six key areas: leadership and executive culture; inclusive company culture; recruitment; retention and development; accountability and sustainability; and supplier diversity. 
 Analyzed and published global multiyear data on Alnylam’s environmental impact. Refined data collection process across scopes 1, 2, and select scope 3 GHG emissions to gather multiyear data and launched a new process to report water usage data for the first time.
 Evolved approach to outreach and inclusion within clinical trials. Trained clinical operations team, based in the U.S. and Europe, on cultural competency frameworks to better serve communities who have traditionally been excluded from clinical trials, as well as set diversity goals for Alnylam trials in common diseases.
 Expanded Alnylam Challengers Health Equity Initiative to Europe. Partnered with innovative non-governmental organizations in the UK, the Netherlands, and Italy to empower refugee populations to rebuild healthy, safe, and productive lives in their adopted homelands.

To learn more about corporate responsibility at Alnylam, download the full 2022 Corporate Responsibility Report here.

About Alnylam Pharmaceuticals

Alnylam (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and prevalent diseases with unmet need. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach yielding transformative medicines. Since its founding 20 years ago, Alnylam has led the RNAi Revolution and continues to deliver on a bold vision to turn scientific possibility into reality. Alnylam’s commercial RNAi therapeutic products are ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO® (lumasiran) and Leqvio® (inclisiran) being developed and commercialized by Alnylam’s partner, Novartis. Alnylam has a deep pipeline of investigational medicines, including six product candidates that are in late-stage development. Alnylam is executing on its “Alnylam P5x25” strategy to deliver transformative medicines in both rare and common diseases benefiting patients around the world through sustainable innovation and exceptional financial performance, resulting in a leading biotech profile. Alnylam is headquartered in Cambridge, MA. For more information about our people, science, and pipeline, please visit www.alnylam.com and engage with us on Twitter at @Alnylam, on LinkedIn, or on Instagram.

Contacts

Alnylam Pharmaceuticals, Inc
Christine Regan Lindenboom
(Investors and Media)
617-682-4340

Josh Brodsky
(Investors)
617-551-8276

“Community Routes: Access to Mental Health Care” helps uninsured patients access healthcare for anxiety and depression, and is a partnership between Direct Relief, the National Association of Free and Charitable Clinics (NAFC) and Teva Pharmaceuticals The expansion of medicine donations for anxiety and depression into seven new states across the United States has the potential to extend the program’s reach to more than 650,000 uninsured patients through 400+ eligible clinicsThe program provides access to a portfolio of donated medicines for anxiety and depression, valued at over $17 million; Teva has committed $2 million of grant funding over two years to free and charitable clinics that care for uninsured patients

SANTA BARBARA, Calif. and PARSIPPANY, N.J., May 03, 2023 /3BL Media/ – Direct Relief, the National Association of Free and Charitable Clinics (NAFC), and Teva Pharmaceuticals, U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced an expansion of medicine donations through their collaborative mental health access program into seven new states to advance access to healthcare for uninsured patients seeking treatment for anxiety and depression.

Through “Community Routes: Access to Mental Health Care,” Teva will continue to provide free and charitable clinics with $2 million in grant funding over two years and make available, on a charitable basis, a portfolio of commonly used generic medications that treat anxiety and depression. Medicines will be available to free and charitable clinics and pharmacies in Direct Relief’s network. The annual value of these medicines provided by Teva is over $17 million this year alone, as determined by their wholesale acquisition cost (WAC).

This announcement expands the program’s medicine donations into seven new states: Alabama, Georgia, Mississippi, North Carolina, South Carolina, Texas and Virginia, increasing the program’s potential reach to more than 650,000 uninsured patients through 400+ eligible free and charitable clinics across 10 total states. The seven new states announced today were selected based on the program’s ability to maximize patient impact, which was determined by assessing unmet need and the presence of a strong network of partner free and charitable clinics in each state.

The program was launched in June 2022, following which the pilot states of Florida, New Jersey and California received product donations and subsequently grant funding to selected clinics.

“As the need for mental health support surges, access to care for people living with anxiety and depression is more pressing than ever,” said Thomas Tighe, CEO and President of Direct Relief. “Direct Relief is deeply grateful to Teva for demonstrating such leadership and dedication and welcomes the opportunity to collaborate with the NAFC and Teva to provide patients with the resources necessary to lead happier and healthier lives.”

“We continue to face a mental health crisis across the U.S. and those directly impacted deserve access to treatment, regardless of background or economic status,” said Sven Dethlefs, PhD, Executive Vice President, North America Commercial at Teva. “Teva is committed to the pursuit of health equity and will continue to bring forward its expertise and resources to help ensure medication availability for anxiety and depression.”

Nicole Lamoureux, President and CEO of NAFC said, “Free and Charitable Clinics are critical to providing care to underserved communities. We’re appreciative of Direct Relief and Teva’s partnership as we chart new strategies to alleviate healthcare inequities and provide access to medicine for some of the most vulnerable among us.”

“Since the pandemic began, addressing mental health has continued to be a priority for our clinic,” shared Fred Bauermeister, Executive Director at Free Clinic of Simi Valley. “With these donations, we have been able to increase access to medications that treat anxiety and depression for the uninsured or underinsured members of our community, generating both progress and a sense of hope.”

A third of adults in the U.S. show symptoms of anxiety, depression, or both.1 Notably, more than 5.5 million adults with a mental illness are uninsured, and almost a third of all adults with a mental illness reported they were not able to receive the treatment they needed.2 Additionally, as a result of the COVID-19 pandemic, racial minorities have experienced higher rates of depression and anxiety compared to their white counterparts. In fact, depression was 15 to 23 times more prevalent for those who identify as Black, Hispanic or Asian.3

About Direct Relief 

A humanitarian organization committed to improving the health and lives of people affected by poverty and emergencies, Direct Relief delivers lifesaving medical resources throughout the U.S. and world to communities in need—without regard to politics, religion, or ability to pay. For more information, visit https://www.DirectRelief.org.

About National Association of Free and Charitable Clinics 

National Association of Free and Charitable Clinics (NAFC) is the only nonprofit 501c (3) organization whose mission is solely focused on the issues and needs of the medically underserved throughout the nation and the more than 1,400 Free and Charitable Clinics that serve them. The NAFC has earned the Platinum Seal of Transparency from GuideStar and a 4-star rating from Charity Navigator. Founded in 2001 and headquartered near Washington, D.C., the NAFC is working to ensure that the medically underserved have access to affordable quality health care and strives to be a national voice promoting quality health care for all. For more information about the NAFC, please visit www.nafcclinics.org.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and innovative medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of innovative and biopharmaceutical products. Learn more at www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to medicine donations through our collaborative mental health access program; our ability to successfully compete in the marketplace, including our ability to develop and commercialize biopharmaceutical products, competition for our innovative medicines, including AUSTEDO®, AJOVY® and COPAXONE®, our ability to achieve expected results from investments in our product pipeline, our ability to develop and commercialize additional pharmaceutical products, and the effectiveness of our patents and other measures to protect our intellectual property rights; our substantial indebtedness; our business and operations in general, including, the impact of global economic conditions and other macroeconomic developments and the governmental and societal responses thereto, and costs and delays resulting from the extensive pharmaceutical regulation to which we are subject; compliance, regulatory and litigation matters, including failure to comply with complex legal and regulatory environments; other financial and economic risks; and other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2022, including in the section captioned “Risk Factors.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statementSource: Teva Pharmaceutical Industries Limited

# # #

_______________________________

1 “Anxiety and Depression.” Centers for Disease Control and Prevention, 2023, https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm

2 “The State of Mental Health in America.” Mental Health America, 2023, https://mhanational.org/issues/state-mental-health-america

3 “The mental health burden of racial and ethnic minorities during the COVID-19 pandemic.” National Institutes of Health, 2022, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365178/

Independent Sector, in partnership with Do Good Institute, has announced the new estimated national value of a volunteer hour:

$31.80 

Volunteers are critical assets to civil society and all of our communities. It’s important for leadership to understand the impact your employee volunteers have on society and social issues, and one of the many ways to do that is by calculating the value of their time.

What does this mean for corporate social responsibility practitioners? 

You spend a lot of time tracking employee volunteer hours, either from company-sponsored programs or through encouraging employees to record their individual engagement activities. Allocating a dollar value to those volunteer hours is a straightforward way to calculate your employee volunteering program’s contributions. It also showcases the company’s overall employee volunteer input.

Additionally, a dollar sign is something most people can relate to, which is why an economic value can become a useful communication tool with the public and internal enterprise decision-makers. It provides you with evidence-based data for communication efforts.

When using this financial measure, we also advise that you account for the other types of value that volunteering brings – whether that’s related to business or societal goals – and the inherent value of employees freely giving their time.

Keep in mind:

At Points of Light, we recognize the debate that exists in the volunteer sector related to assigning an economic value to volunteering. There are practical and philosophical issues with using this approach, as counting hours provides only a partial picture of the value that volunteers contribute to communities. It is also important to keep in mind that when referring to monetary expressions of value and explaining the costs and benefits of volunteering and volunteer programs in dollars, we are not disqualifying or rivaling other forms of valuation – qualitative or quantitative. The discussion paper put together by Volunteer Canada on the topic provides an insightful look into the practice of determining the economic value of volunteering.The $31.80 value of a volunteer hour is valid for the United States only.Generally, the $31.80 value of a volunteer hour can be applied to a wide range of traditional volunteer activities. For specialized, skilled pro bono services (especially if your company has a formalized pro bono program), we suggest looking into the valuation provided by the Taproot Foundation which announced that the average hourly value of pro bono service in 2019 is $195. Both forms of volunteering are critical to providing nonprofits with resources.

Learn more about the methodology behind Independent Sector’s new Value of Volunteer Time, and get the updated figures for all 50 states, the District of Columbia and Puerto Rico.

CINCINNATI, May 2, 2023 /3BL Media/ – Small Business Week 2023 is April 30 to May 6 and Fifth Third Bank, National Association, is proud that it can offer local small businesses guidance, products, and services at every stage of the business lifecycle. Once a small business owner is nearing retirement, they often face the challenge: keep it in the family or sell to an external party? However, the most successful transitions are those where the owner starts planning sooner rather than later and treats transition planning as a business strategy rather than an ending event.

Regardless of where clients are in the process, Fifth Third’s Business Transition Advisory Team offers five key considerations to help you navigate your personal wealth plan.

The appropriate team of experts can identify and map out the complexities of transition plans and bring objectivity to what can be personally and emotionally challenging decisions. Such a team usually consists of an investment banker, wealth advisor, business banker, CPA, attorney (business and estate planning), valuation expert and insurance advisor.

These are external experts who can address key areas, provide realistic timelines, identify opportunities to increase eventual value of a business while minimizing tax impacts, and define and map financial goals after the sale.

But … sometimes plans change 

Cedar Animal Hospital in Northern Kent County Michigan is AAHA-credited (only 15 percent of U.S. hospitals are) and has been making a difference in the lives of animals and families in Western Michigan and surrounding areas for more than 30 years. In 2017, co-owners Dr. Lawrence Nauta, DVM, and Dr. Judy Nauta, DVM, began non-traditional hours with 24/7 staffing to address the growing need for emergency pet care.

Five years ago, Dr. Nauta thought about retiring, but that didn’t last long. He wasn’t fulfilled because animals are everything for him and his wife.

“I tried retirement and even semi-retirement for a little while,” he said. “It wasn’t me. I think this is my retirement. I want to help people and their animals as long as I’m capable.”

And help they have. Dr. Nauta has been consistently busy pre-, during and post-pandemic. Last year, Cedar’s had 17,500 patient visits, many of which were referred from overwhelmed emergency clinics from all around the state of Michigan. Patients came from across the state, Chicago, Michigan’s upper peninsula and Indiana. Because of the pandemic, more people wanted their pets to be seen, but getting immediate care can be difficult.

The couple began working on a plan to address the backlog that many vets are experiencing. They enlisted the help of their trusted advisor, Fifth Third Business Banking Relationship Manager Michael Joseph to seek guidance and funding to expand the emergency side and capabilities of Cedar’s client practices. Joseph helped the couple secure an SBA 504 loan to construct a building that would nearly triple their square footage, allow for more dedicated intensive care unit professionals, and add state of the art equipment.

On April 19, Cedar Animal Hospital hosted a ribbon cutting ceremony to celebrate a 9,000+ square-foot urgent care and emergency addition to its building.

The new emergency center provides:

Waiting room and digital patient queue to see a pet’s progressPrivate exam roomsAdvanced in-house diagnostics— including laboratory, digital radiography, ultrasound, PCR testing and a CT scanDedicated exotic spaceSelf-contained isolation roomsLarge dog spaceAn additional 100 parking spaces

Patient admissions and care will be expanding rapidly with several new doctors arriving this spring and summer. The plan is to add 40 new jobs and have the building open to the public by the middle of October.

Buying, selling, and transitioning a business can all lead to an experience of a lifetime when the right team of industry experts are engaged early – from start to finish line.

Dr. Nauta said that this expansion was worth every penny.

“This is what I’ve devoted my life to,” he said. “To see this happen feels like an out-of-body experience; it’s so exciting. I’m just so thankful that this dream became a reality.”

About Fifth Third

Fifth Third is a bank that’s as long on innovation as it is on history. Since 1858, we’ve been helping individuals, families, businesses and communities grow through smart financial services that improve lives. Our list of firsts is extensive, and it’s one that continues to expand as we explore the intersection of tech-driven innovation, dedicated people and focused community impact. Fifth Third is one of the few U.S.-based banks to have been named among Ethisphere’s World’s Most Ethical Companies® for several years. With a commitment to taking care of our customers, employees, communities and shareholders, our goal is not only to be the nation’s highest performing regional bank, but to be the bank people most value and trust.

Fifth Third Bank, National Association is a federally chartered institution. Fifth Third Bancorp is the indirect parent company of Fifth Third Bank, and its common stock is traded on the NASDAQ® Global Select Market under the symbol “FITB.” Investor information and press releases can be viewed at www.53.com. Deposit and credit products offered by Fifth Third Bank, National Association. Member FDIC.

CONTACTS 
Beth Oates (Media Relations) 
Beth.Oates@53.com | 313-230-9002 
Chris Doll (Investor Relations) 
Christopher.Doll@53.com | 513-534-2345

We recently added UK data to the Violations First data set on legal issues. We have now found another data set on US issues. Lequity Group collects, organizes, and analyzes data from the thousands of federal, state, and local courts and regulatory bodies across the country. This difficult task requires Lequity to interface with and ingest data from disparate, scattered, and inconsistent legal systems. It uses this information to provide informative ESG data about the types, amounts, allegations, and outcomes of lawsuits and regulatory actions filed against companies.

We were able connect 1,904 of the more than 2,000 names that Lequity tracks with our CSRHub rating set. Lequity is able to both provide a current “Scoreboard” of litigation issues and a historic perspective. We used data from June of 2022 and June of 2021 to see if this new legal system signal is present within CSRHub’s consensus ratings.

There is some correlation at the top level. As you can see below, entities that have a high Lequity rating (meaning they have a lot of litigation activity) have lower Overall CSRHub scores.

See Higher Lequity Ratings Correlated With Lower CSRHub Overall Scores

We found a correlation also in the changes in Lequity’s scores—companies that improved their legal issue performance also saw some improvement in their Overall CSRHub rating. By drilling down into the 12 CSRHub subcategories, we were able to find the most connection between Lequity’s score and CSRHub’s Compensation & Benefits, Diversity & Labor Rights, and Environment Policy & Reporting ratings.

See Regression Statistics 

As Lequity’s coverage and time history grows, we will look for more relationships. Of course, as more people learn of this firm’s work, it will have more influence on the consensus view of the entities it rates. This will also increase the connection between our scores.

Bahar Gidwani is CTO and Co-founder of CSRHub. He has built and run large technology-based businesses for many years. Bahar holds a CFA, worked on Wall Street with Kidder, Peabody, and with McKinsey & Co. Bahar has consulted to a number of major companies and currently serves on the board of several software and Web companies. He has an MBA from Harvard Business School and an undergraduate degree in physics and astronomy. He plays bridge, races sailboats, and is based in New York City.

About CSRHub

CSRHub offers one of the world’s broadest and most consistent set of Environment, Social, and Governance (ESG) ratings, covering 50,000 companies. Its Big Data algorithm combines millions of data points on ESG performance from hundreds of sources, including leading ESG analyst raters, to produce consensus scores on all aspects of corporate social responsibility and sustainability. CSRHub ratings can be used to drive corporate, investor and consumer decisions. For more information, visit www.CSRHub.com. CSRHub is a B Corporation.

IRVINE, Calif., May 2, 2023 /3BL Media/ – With bold ambitions to operate 10,000 restaurants in the coming years, Taco Bell acknowledges its responsibility to balance global expansion with intentional impact. In pursuit of parent company Yum! Brands’ broader climate efforts to reduce greenhouse gas emissions by nearly 50% by 2030, Taco Bell is taking bigger steps to improve the environmental effects of its supply chain, especially for one of its top-selling ingredients. Taco Bell is now partnering with its long-time supplier Cargill and the National Fish and Wildlife Foundation (NFWF) to implement conservation and regenerative agriculture practices across cattle grazing lands.

Taco Bell’s innovative approach to shaking up the status quo reaches beyond just its menu, extending even into its supply chain. Leveraging the expertise of NFWF, this partnership will support beef producers with technical and financial tools to expand their regenerative ranching practices, from conserving grassland ecosystems to improving river water quality and biodiversity. The commitment from Cargill and Taco Bell will allocate $2 million and will leverage up to $2 million in federal funds for a combined total of $4 million in new grants over the next four years.

“We’re all about democratizing access to quality, flavorful meals at an affordable price,” said Missy Schaaphok, Director of Global Nutrition & Sustainability at Taco Bell. “What people don’t see directly on our menu is how we also prioritize sustainability just as much as craveability.”

While the grasslands where beef cattle live might look vast and bountiful, the land is under threat from climate change, invasive species, limited water and residential developments. This partnership is estimated to conserve and restore tens of thousands of acres and benefit the inhabiting wildlife, from elk to songbirds, all while giving cattle abundant grazing land. These efforts are expected to sequester up to 44,000 metric tons of carbon dioxide equivalent per year in 2030.

Organizations supporting ranchers as they seek to implement regenerative agricultural practices across the Intermountain West can submit applications starting May 4 until August 3, with projects to start in 2024. The program will impact a vast region stretching from the Colorado Rockies to the Great Basin, including local organizations and communities across portions of seven states: Colorado, Idaho, Montana, Nevada, Oregon, Utah and Wyoming.

“Through the voluntary implementation of managed grazing practices, benefits to both rancher operations and wildlife are realized,” said Jeff Trandahl, executive director and CEO of NFWF. “Taco Bell, in partnership with Cargill, will help organizations working directly with ranchers in the Intermountain West to implement important changes, providing better habitat for wildlife, increasing carbon sequestration, and creating a more resilient ecosystem for people and for the species that depend on these rangelands for their very survival.”

“At Cargill, we pride ourselves on connecting our customers to partners such as NFWF that can help drive sustainability efforts starting with nature and the rancher,” said Jeffrey Fitzpatrick, BeefUp Sustainability Program Lead at Cargill. “As beef is a beloved ingredient at Taco Bell, it’s our job as their trusted supplier to encourage and support efforts that increase the sustainability of the supply chain through investment and collaboration.”

With purchased food in Yum! Brands’ supply chain producing more than two-thirds of its emissions, this program will be valuable in helping to sustain America’s natural resources while still feeding the taco nation.

“Collaboration with ranchers and other supply chain partners is needed now more than ever, especially with food and farming being critical avenues for positive climate solutions,” said Jon Hixson, Chief Sustainability Officer at Yum! Brands. “We’re proud to have partners in the National Fish and Wildlife Foundation and Cargill that acknowledge the great responsibility we carry to both Taco Bell fans and the environment.”

Taco Bell continues to prioritize other commitments and collaborative efforts to improve sourcing efforts, including membership in the U.S. Roundtable for Sustainable Beef and ongoing initiatives to improve the sustainability of its packaging suite.

About Taco Bell Corp. 
For more information about Taco Bell, visit our website at www.TacoBell.com, our Newsroom at www.TacoBell.com/news or www.TacoBell.com/popular-links. You can also stay up to date on all things Taco Bell by following us on LinkedIn, TikTok, Taco Bell’s Twitter, Instagram, Facebook, and subscribing to our YouTube channel.

About Cargill 
Cargill helps the world’s food system work for you. We connect farmers with markets, customers with ingredients and families with daily essentials—from the foods they eat to the floors they walk on. Our 160,000 team members around the world innovate with purpose, empowering our partners and communities as we work to nourish the world in a safe, responsible, sustainable way.

From feed that reduces methane emissions to waste-based renewable fuels, the possibilities are boundless. But our values remain the same. We put people first. We reach higher. We do the right thing. It’s how we’ve met the needs of the people we call neighbors and the planet we call home for 157 years—and how we’ll do so for generations to come. For more information, visit Cargill.com and our News Center.

About the National Fish and Wildlife Foundation 
Chartered by Congress in 1984, the National Fish and Wildlife Foundation (NFWF) protects and restores the nation’s fish, wildlife, plants and habitats. Working with federal, corporate, foundation and individual partners, NFWF has funded more than 6,000 organizations and generated a total conservation impact of $8.1 billion. Learn more at nfwf.org.

WILMINGTON, Del., May 2, 2023 /3BL Media/ – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today introduces Ti-Pure™ TS-6700, a high-performance, TMP- and TME-free TiO2 grade designed for waterborne architectural coatings applications.

Designed to meet the emerging sustainability requirements facing coating producers, Ti-Pure™ TS-6700 is TMP- and TME-free and is made with 100% renewable electricity Ti-Pure™ TS-6700 is designed and produced with a bio-based organic surface treatment that brings together pigment performance, paint processing, and sustainability. This grade meets current as well as anticipated regulatory and ecolabel requirements for materials. Ti-Pure™ TS-6700 is a drop-in replacement for blue undertone TiO2 grades used in waterborne architectural coatings and boasts excellent dispersibility and outstanding durability. For some formulations, additional processing and sustainability benefits may be achieved, such as reduced dispersant demand, faster wet-in time, and a reduction in grind energy.

“Regulators have made their intentions clear for manufacturers to begin making plans to eliminate TMP from product formulations. As such, Ti-Pure™ TS-6700 was developed to provide our coatings customers with a solution that meets these evolving requirements while still empowering them to create products with best-in-class performance,” said Cristiana Borrelli, Senior Director, Global Technology and Marketing at Chemours. “This launch is a reflection of our commitment to serving as a true partner to our customers in support of their current sustainability goals while positioning them for long-term success by keeping an eye on future needs.”

Ti-Pure™ TS-6700 is being produced with 100% renewable electricity to help customers advance their sustainability goals of reducing CO2 emissions. Ti-Pure™ TS-6700 is the newest grade in the Ti-Pure™ Sustainability (TS) series, a portfolio of products that feature sustainability-driven value propositions and support Chemours’ aspiration to become the most sustainable TiO2 enterprise in the world. Ti-Pure™ TS-6700 will carry the health and wellness and climate impact product sustainability designations.

“At Chemours, we believe innovation that will move our industry forward must first and foremost center around the coatings producer. Only by deeply understanding their products, production processes, industry regulations, and ultimate goals can innovations be achieved that advance the state of coatings products,” said Carlos Verdejo, Vice President of Sales and Marketing at Chemours. “By meeting our customers’ need to easily replace TMP grades used in ecolabel paints, we hope to build our customers’ confidence in their ability to be compliant while advancing their sustainable product design.”

About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our flagship products include prominent brands such as Ti-Pure™, Opteon™, Freon™, Teflon™, Viton™, Nafion™, and Krytox™. The company has approximately 6,400 employees and 29 manufacturing sites serving approximately 3,300 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words “believe,” “expect,” “will,” “anticipate,” “plan,” “estimate,” “target,” “project” and similar expressions, among others, generally identify “forward-looking statements,” which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized, such as full year guidance relying on models based upon management assumptions regarding future events that are inherently uncertain. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours’ control. Matters outside our control, including general economic conditions and the COVID-19 pandemic, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 and in our Annual Report on Form 10-K for the year ended December 31, 2022. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

INVESTORS
Jonathan Lock
SVP, Chief Development Officer
+1.302.773.2263

Kurt Bonner
Manager, Investor Relations
+1.302.773.0026
investor@chemours.com

NEWS MEDIA
Thomas Sueta
Corporate Communications Director
+1.302.773.3903
media@chemours.com

Source: The Chemours Company

 

View original content here

New Holland Agriculture, a brand of CNH Industrial, has launched a mobile medical dispensary (MMD) in Pune, India. As part of a corporate social responsibility (CSR) initiative, the dispensary will provide basic healthcare services to people in need within a 35-40 km radius of the city. New Holland aims to reach over 15,000 individuals each year.

Operated by Medihelp Foundation, the MMD will offer point-of-care diagnostics, including blood glucose testing and screening for hypertension and diabetes. It will continue to support through regular follow-up checks and provide patient referrals as needed.

Kavita Sah, New Holland India CSR Lead, said, “New Holland Agriculture is committed to giving back to the communities surrounding our facilities, and our mobile medical dispensary is a step towards caring for the people that live there. Through this initiative, we are dedicated to providing basic healthcare services to people in need. We hope to make a positive impact on their lives and contribute to the overall wellbeing of their communities.”

Staffed by a doctor and a paramedic, the MMD is expected to visit over 20 villages in the region. The initiative is an extension of New Holland Agriculture’s mobile ambulance project, which has been operational in 15 villages around Greater Noida since 2016, treating over 16,000 people every year.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.